Tricyclic HIV integrase inhibitors: Potent and orally bioavailable C5-aza analogs

被引:19
|
作者
Jin, Haolun [1 ]
Wright, Matthew [1 ]
Pastor, Richard [1 ]
Mish, Michael [1 ]
Metobo, Sammy [1 ]
Jabri, Salman [1 ]
Lansdown, Rachael [1 ]
Cai, Ruby [1 ]
Pyun, Peter [1 ]
Tsiang, Manuel [1 ]
Chen, Xiaowu [1 ]
Kim, Choung U. [1 ]
机构
[1] Gilead Sci Inc, Dept Med Chem, Foster City, CA 94404 USA
关键词
D O I
10.1016/j.bmcl.2008.01.018
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of C5-aza tricyclic HIV integrase inhibitors was prepared. A highly potent and orally bioavailable compound ( compound 9) was identified and selected for development. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1388 / 1391
页数:4
相关论文
共 50 条
  • [21] Optimization of a series of potent, selective and orally bioavailable SYK inhibitors
    Grimster, Neil P.
    Gingipalli, Lakshmaiah
    Barlaam, Bernard
    Su, Qibin
    Zheng, XiaoLan
    Watson, David
    Wang, Haixia
    Simpson, Iain
    Pike, Andy
    Balazs, Amber
    Boiko, Scott
    Ikeda, Timothy P.
    Impastato, Anna C.
    Jones, Natalie H.
    Kawatkar, Sameer
    Kemmitt, Paul
    Lamont, Scott
    Patel, Joe
    Read, Jon
    Sarkar, Ujjal
    Sha, Li
    Tomlinson, Ronald C.
    Wang, Haiyun
    Wilson, David M.
    Zehnder, Troy E.
    Wang, Lianghe
    Wang, Peng
    Goldberg, Frederick W.
    Shao, Wenlin
    Fawell, Stephen
    Dry, Hannah
    Dowling, James E.
    Edmondson, Scott D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (19)
  • [22] Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf Inhibitors
    Gould, Alexandra E.
    Adams, Ruth
    Adhikari, Sharmila
    Aertgeerts, Kathleen
    Afroze, Roushan
    Blackburn, Christopher
    Calderwood, Emily F.
    Chau, Ryan
    Chouitar, Jouhara
    Duffey, Matthew O.
    England, Dylan B.
    Farrer, Cheryl
    Forsyth, Nancy
    Garcia, Khristofer
    Gaulin, Jeffery
    Greenspan, Paul D.
    Guo, Ribo
    Harrison, Sean J.
    Huan, Shih-Chung
    Iartchouk, Natalia
    Janowick, Dave
    Kim, Mi-Sook
    Kulkarni, Bheemashankar
    Langston, Steven P.
    Liu, Jane X.
    Ma, Li-Ting
    Menon, Saurabh
    Mizutani, Hirotake
    Paske, Erin
    Renou, Christelle C.
    Rezaei, Mansoureh
    Rowland, R. Scott
    Sintchak, Michael D.
    Smith, Michael D.
    Stroud, Stephen G.
    Tregay, Ming
    Tian, Yuan
    Veiby, Ole P.
    Vos, Tricia J.
    Vyskocil, Stepan
    Williams, Juliet
    Xu, Tianlin
    Yang, Johnny J.
    Yano, Jason
    Zeng, Hongbo
    Zhang, Dong Mei
    Zhang, Qin
    Galvin, Katherine M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (06) : 1836 - 1846
  • [23] A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors
    Tucker, Thomas J.
    Embrey, Mark W.
    Alleyne, Candice
    Amin, Rupesh P.
    Bass, Alan
    Bhatt, Bhavana
    Bianchi, Elisabetta
    Branca, Danila
    Bueters, Tjerk
    Buist, Nicole
    Ha, Sookhee N.
    Hafey, Mike
    He, Huaibing
    Higgins, John
    Johns, Douglas G.
    Kerekes, Angela D.
    Koeplinger, Kenneth A.
    Kuethe, Jeffrey T.
    Li, Nianyu
    Murphy, BethAnn
    Orth, Peter
    Salowe, Scott
    Shahripour, Aurash
    Tracy, Rodger
    Wang, Weixun
    Wu, Chengwei
    Xiong, Yusheng
    Zokian, Hratch J.
    Wood, Harold B.
    Walji, Abbas
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (22) : 16770 - 16800
  • [24] A potent and orally active HIV-1 integrase inhibitor
    Egbertson, Melissa S.
    Moritz, H. Marie
    Melamed, Jeffrey Y.
    Han, Wei
    Perlow, Debra S.
    Kuo, Michelle S.
    Embrey, Mark
    Vacca, Joseph P.
    Zrada, Matthew M.
    Cortes, Amanda R.
    Wallace, Audrey
    Leonard, Yvonne
    Hazuda, Daria J.
    Miller, Michael D.
    Felock, Peter J.
    Stillmock, Kara A.
    Witmer, Marc V.
    Schleif, William
    Gabryelski, Lori J.
    Moyer, Gregory
    Ellis, Joan D.
    Jin, Lixia
    Xu, Wei
    Braun, Matthew P.
    Kassahun, Kellem
    Tsou, Nancy N.
    Young, Steven D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) : 1392 - 1398
  • [25] Indole Derivatives Are Potent Inhibitors of HIV Integrase
    Selvam, Periyasamy
    Maddali, Kasthuraiah
    Pommier, Yves
    ANTIVIRAL RESEARCH, 2009, 82 (02) : A42 - A42
  • [26] From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors
    Liang, Jun
    Labadie, Sharada
    Zhang, Birong
    Ortwine, Daniel F.
    Patel, Snahel
    Vinogradova, Maia
    Kiefer, James R.
    Mauer, Till
    Gehling, Victor S.
    Harmange, Jean-Christophe
    Cummings, Richard
    Lai, Tommy
    Liao, Jiangpeng
    Zheng, Xiaoping
    Liu, Yichin
    Gustafson, Amy
    Van der Porten, Erica
    Mao, Weifeng
    Liederer, Bianca M.
    Deshmukh, Gauri
    An, Le
    Ran, Yingqing
    Classon, Marie
    Trojer, Patrick
    Dragovich, Peter S.
    Murray, Lesley
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (13) : 2974 - 2981
  • [27] Solid Phase Synthesis of Novel Pyrrolidinedione Analogs as Potent HIV-1 Integrase Inhibitors
    Pendri, Annapurna
    Troyer, Timothy L.
    Sofia, Michael J.
    Walker, Michael A.
    Naidu, B. Narasimhulu
    Banville, Jacques
    Meanwell, Nicholas A.
    Dicker, Ira
    Lin, Zeyu
    Krystal, Mark
    Gerritz, Samuel W.
    JOURNAL OF COMBINATORIAL CHEMISTRY, 2010, 12 (01): : 84 - 90
  • [28] Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT
    Parthasarathy, Saravanan
    Henry, Kenneth
    Pei, Huaxing
    Clayton, Josh
    Rempala, Mark
    Johns, Deidre
    De Frutos, Oscar
    Garcia, Pablo
    Mateos, Carlos
    Pleite, Sehila
    Wang, Yong
    Stout, Stephanie
    Condon, Bradley
    Ashok, Sheela
    Lu, Zhohai
    Ehlhardt, William
    Raub, Tom
    Lai, Mei
    Geeganage, Sandaruwan
    Burkholder, Timothy P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (10) : 1887 - 1891
  • [29] Identification of potent, orally bioavailable nonnucleoside HCV RNA polymerase inhibitors
    Dragovich, Peter S.
    Brooks, Jennifer
    Bartkowski, Darian M.
    Blazel, Julie K.
    Dao, Kimkim
    Ellis, David A.
    Gobbi, Alberto
    Kamran, Ruhi
    Kim, Sun Hee
    LeBrun, Laurie A.
    Li, Lian-Sheng
    Murphy, Douglas E.
    Nolan, Thomas G.
    Norris, Daniel A.
    Patel, Rupal
    Ruebsam, Frank
    Sergeeva, Maria V.
    Shah, Amit M.
    Showalter, Richard E.
    Stankovic, Nebojsa
    Sun, Zhongxiang
    Tran, Chinh V.
    Tran, Martin T.
    Tsan, Mei
    Webber, Stephen E.
    Xiang, Alan X.
    Zhao, Jingjing
    Kirkovsky, Leo
    Zhou, Yuefen
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [30] Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors
    Garton, Neil S.
    Barker, Michael D.
    Davis, Rob P.
    Douault, Clement
    Hooper-Greenhill, Edward
    Jones, Emma
    Lewis, Huw D.
    Liddle, John
    Lugo, Dave
    McCleary, Scott
    Preston, Alex G. S.
    Ramirez-Molina, Cesar
    Neu, Margarete
    Shipley, Tracy J.
    Somers, Don O.
    Watson, Robert J.
    Wilson, David M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (19) : 4606 - 4612